Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Protons × Breast × Clear all

Phase

Status

Unknown 3 Active not recruiting 3 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Gynecologic 2 Gastrointestinal 2 Head & Neck 1 Genitourinary 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 334 Paclitaxel 322 Cyclophosphamide 297 Docetaxel 275 Capecitabine 184 Doxorubicin 174 Letrozole 164 Tamoxifen 142 Carboplatin 129 Fulvestrant 120 Bevacizumab 113 Lapatinib 109 Anastrozole 108 exemestane 106 Gemcitabine 101 Radiotherapy 97 Epirubicin 97 palbociclib 77 Exercise 73 Fluorouracil 72 Vinorelbine 71 Surveys and Questionnaires 71 Albumin-Bound Paclitaxel 66 pertuzumab 65 Filgrastim 62 Magnetic Resonance Spectroscopy 56 130-nm albumin-bound paclitaxel 56 eribulin 55 Everolimus 55 Cisplatin 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00614172 2023-09-21

Proton Therapy for Early Stage Breast Cancer

Loma Linda University

Phase NA Completed

50 enrolled 12 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡